| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $19.86M | $30.67M | $30.34M | $28.52M | $14.65M |
| R&D | $10.21M | $16.96M | $16.83M | $14.06M | $7.35M |
| SG&A | $9.65M | $12.64M | $13.51M | $14.46M | $7.31M |
| Operating Income | -$19.44M | -$30.44M | -$30.34M | -$28.52M | -$14.65M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$19.44M | -$30.44M | -$30.01M | -$28.52M | -$14.65M |
| EPS (basic) | -4.4400 | -0.5700 | -1.0000 | -1.3600 | -1.4700 |
| EPS (diluted) | -4.4400 | -0.5700 | -1.0000 | -1.3600 | -1.4700 |
| Shares (diluted) | $4.37M | $53.55M | $29.86M | $20.97M | $9.97M |